Breast Cancer
Studies: INGN 241 enhances antitumor effects of Herceptin
Published in Cancer Weekly, May 4th, 2004
INGN 241, a product candidate designed to deliver the MDA-7/IL-24 gene to tumor cells, is being developed by Introgen Therapeutics, Inc., (INGN) and is in phase I and phase II clinical trials in a variety of cancers.
The data were generated in an ongoing collaboration between researchers at Introgen and the University of Texas M.D. Anderson Cancer Center.
Dr. Sunil Chada, Introgen's director of research and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-05-04)
More Articles from Cancer Weekly
- Breast & GI Cancer
Sentinel node biopsy should be standardized - Cancer
Updated nausea and vomiting treatment guidelines offered to cancer patients - Cancer Outcomes
There may be a link between Internet use and cancer outcomes - Diagnostics
Researchers develop polarized reflectance spectroscopy for precancer detection - Oncogenesis
Oncogenesis from single base mutation in IRES of Epstein-Barr nuclear antigen 1 - Acute Lymphoblastic Leukemia
Molecular analyses of ALL suggest strategies for more effective treatments - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
